Section

Markets

Earnings, deals, financings and the public companies behind peptides.

Oct 31Technology Org
Challenge: Enabling oral peptide delivery to achieve bioavailability (BAV) in vivo greater than 4%
By Tom Reyes
Oct 30Yahoo Finance
Novo Nordisk (NVO) Sets New 2030 Goals As GLP 1 Competition Builds
By Tom Reyes
Oct 30Yahoo Finance
Eli Lilly raises earnings outlook as obesity drug demand drives strong growth, UBS says
By Tom Reyes
Oct 30BioPharma Dive
Earnings roundup: Lilly’s unwavering momentum, Novartis’ rebound and GSK’s waiting game
By Tom Reyes
Oct 30Bioengineer.org
Dual-Drug Liposomes With YIGSR Peptide Target Breast Tumor Cells in Mice
By Tom Reyes
Oct 29The Journal of physiology
Combined time-restricted feeding and resistance training enhance tirzepatide-induced improvements in adiposity and whole-body insulin sensitivity in female mice
By Tom Reyes
Oct 29LiveNOW from FOX
HHS eases restrictions on certain unapproved peptides
By Tom Reyes
Oct 29Stocks Down Under
Protagonist Therapeutics (NDQ:PTGX): Can Oral Peptides Disrupt Biologics? Yes, Seriously Peptides!
By Tom Reyes
Oct 29Reuters
Eli Lilly lifts revenue outlook as weight-loss shots offset Foundayo sales miss, shares jump
By Tom Reyes
Oct 29Yahoo Finance
Eli Lilly stock jumps as drugmaker raises outlook on booming sales of diabetes and obesity treatments
By Tom Reyes
Oct 29Nature
Physicochemical rule-embedded generative modeling for constrained peptide therapeutics
By Tom Reyes
Oct 29Yahoo
New peptide policy raises safety concerns over weight-loss drugs
By Tom Reyes
Oct 29CNBC
Eli Lilly hikes sales outlook, as CEO says there's room for 'dramatic' obesity market expansion
By Tom Reyes
Oct 29Bioengineer.org
Thymosin added to colorectal cancer therapy shows immune signals but evidence falls short
By Tom Reyes
Oct 28Yahoo Finance
Peptides Costa Rica Announces Sponsorship of Professional Boxer Ziggy Myrie Samudio
By Tom Reyes
Oct 28TradingView
Eli Lilly Stocks Rise After Retatrutide's Head-to-Head Trial Results
By Tom Reyes
Oct 28BioPharm International
Why Highly Potent Peptides Can Succeed with Low Oral Bioavailability
By Tom Reyes
Oct 28BioPharm International
The Truth About Oral Peptide Delivery in 2026
By Tom Reyes
Oct 28TradingView
NURS: A 50-state B2B healthcare platform scales on license growth and peptide-regulatory tailwinds
By Tom Reyes
Oct 27Yahoo Finance
Jennifer Woodward's New Book Debunks Peptide Myths for Women's Health
By Tom Reyes
Oct 27Yahoo Finance
Melex Technologies Inc. Launches Simple Life Science, a Life Science Company Supplying Peptide and Small Molecule API and Custom Synthesis to Laboratories
By Tom Reyes
Oct 27BusinessWorld Online
Understanding Glucagon Like Peptides: Their Role and Medical Uses
By Tom Reyes
Oct 27citybuzz -
PolyPeptide Shareholders Approve Board Overhaul and Removal of Transfer Restrictions Ahead of Samsung Biologics Takeover
By Tom Reyes
Oct 26TradingView
PolyPeptide announces results of the extraordinary general meeting of shareholders
By Tom Reyes
Oct 26BioPharm International
How Lipid-Based Softgels Protect Oral Peptides from Degradation
By Tom Reyes
Oct 26BioPharma Dive
Novel protein and peptide therapeutics
By Tom Reyes
Oct 2524/7 Wall St.
Viking Therapeutics reports Q3 results October 28 after launching oral VK2735 Phase 3
By Tom Reyes
Oct 24Yahoo Finance
Should Peptide Purification Launch Require Action From DuPont (DD) Investors?
By Tom Reyes
Oct 23Trend Hunter
Copper Peptide Beauty Products: TheraCopper Launches Skincare and Haircare Collection
By Tom Reyes
Oct 23TechBullion
Peptide Ads: Why Google and Facebook Keep Saying No, and What Gets Approved?
By Tom Reyes
Oct 23FinancialContent
Peptide Sciences Closed: California Trim Clinic Offers Physician-Prescribed Peptide Therapy Options
By Tom Reyes
Oct 23MedCity News
Gilead pays nearly $1.3 billion for PepStar oral IL-23 receptor peptide
By Tom Reyes
Oct 23BioPharm International
Gilead to buy oral IL-23 receptor peptide HCXT-2001 for $1.275 billion
By Tom Reyes
Oct 23Longevity.Technology
Immorta Bio advances nine-amino-acid senolytic peptide against zombie cells
By Tom Reyes
Oct 22TradingView
Vector Science unveils peptide-matrix microneedle platform for transdermal delivery
By Tom Reyes
Oct 22kalkine.ca
Vanta Holdings Inc. (CN:VNTA) Gains 3.75% as Peptide Therapy Expansion, Fresh Financing and Longevity Market Opportunities Lift Investor Optimism
By Tom Reyes